- Posts
- Discussion Board
-
-
-
Re: Cheerleaders in Lab Coats
-
Come on folks, let's stick to the topic, there's plenty here to discuss. If someone's idea doesn'...
-
Re: Cheerleaders in Lab Coats
-
-
-
-
Re: Cheerleaders in Lab Coats
-
Who pays for GMWB (partial, in sup...
Note that even if the insurance assets underlying the variable annuity subaccounts have a zero return or even small positive returns, the floor guarantee can still be triggered. This is b/c benefit payments decline whenever subaccount performance is lower than the assumed investment rate (AIR), for example, 5%. To that extant the insurer raises its mortality and expense (M&E) risk charge to cover this floor guarantee. That actually makes a triggering of the floor guarantee more likely b/c the underlying funds must perform even better just to offset the additional charge.
Risks associated with offering such a floor guarantee can be partially transferred to the annuitant, depending on product construction. For example, future benefit payments could be reduced to extant necessary (but never lower than the floor) to cover any shortfall that had previously arisen due to poor fund performance. Effectively, this has the annuitant borrowing from hims/ her self, in the sense that he /she is really receiving an advance against future benefit payments to make up the shortfall.
However, the insurer must make up the current period shortfall from its own assets but it has reduced liability-the present value of future annuity benefits exclusive of the floor benefit guarantee-by a like amount. The cost of such product construction to the insurer is less than one where the insurer alone funds 100% of any shortfall b/c once benefit payments again equal or exceed the floor level, the insurer is paying a lower number of annuity units par payment than the original number. B/c any advance serves as a negative premium that reduces the number of annuity units the value of which is payable per benefit period, it may take longer for the benefit level to climb back up to the floor.
Such an approach to payout floors-and to other embedded option guarantees-increases reliance by annuitants on the financial strength and claims paying ability of the issuing insurer, possibly for many decades into the future. With inclusion of floor benefits, annuitants now must count on the insurer s ability to chip-in additional funds when needed, perhaps for a long time into the future. Such a design concept changes the nature of the variable annuity from being one of the least risky products from an insurance company s perspective, b/c previously investment risk was borne by annuitants in the form of fluctuating benefits, to one of the most risky, b/c the insurer now guarantees subaccount performance above a certain level, something over which it has little or no control. The insurer could however mitigate it with imposing asset allocation requirements or purchasing derivatives. In such cases there is a price tag associated with it to be borne by the insurer, by the annuitant, or by both.
Such variations of VAs exist as insurers attempt to differentiate their product offerings from those of competitors, seeking to remain in the vanguard of retirement income product innovation.
While mentioning to word vanguard, could it be that the above reasons influenced the Vanguard Group of mutual funds NOT to offer GMWBs in their low fees VAs?
-
Re: Cheerleaders in Lab Coats
-
-
-
-
Re: Cheerleaders in Lab Coats
-
300 BP/yr is a reasonably accurate figure for the total annual cost of
a fully-commission...
John,
This
is interesting...is it fair to say that you're an exceptional case,
rather than a typical one? Meaning, with respect to ongoing services
and choice of trail over lump-sum.
I'd be interested to see what
the typical "service mix received" is for a VA purchaser, over the life
of the product...and how it compares when the agent opts for lump sum
rather than trail. Then a comparison to some other approaches, whether
it's RR/mutual funds, RIA/mutual funds, etc. So few VAs are annuitized,
and so much VA activity is contract replacement, that the sample might
not be very big -- but they're out there.
To generalize it -- I
think a consumer sees a very wide range of service levels across
service providers. I believe that's
true both within each pay/licensing model, and among them. But my
belief is that the VA+lump is likely to be a "turnkey" product with
much less ongoing advice associated with it (perhaps none other than contract-related). That's certainly been the
case with inbound clients, but then again, perhaps that's the reason
they left the firm that sold them the VA.
So to me
it's a bit of a throw-away for a study to say "well they incur the cost
of the VA but they won't need to pay any advisory fees." It says to me they might have a narrow view of the expected service levels for this type of client. A lot
is going to come up that will require new advice and new costs for that
advice because the original agent is unwilling (or unable, because of licensing) to provide it.
Seven years from now the client has a grandchild, wants to factor her
into the overall mix somehow...is that agent who took the lump going to
do that work, without the client incurring an additional cost not
accounted for in the study? Or - last year the IRA-to-Charity
opportunity was there for MRDs, if that was well into
annuitization did the lump-pay agent who sold it in 1998 call and solicit that idea (even
though it wouldn't lead to a dime of compensation)? These are
completely routine questions to address in the context of a long-term
advisory relationship for a retiree. I'm highly skeptical the typical lump-pay agent
is doing that stuff -- if in fact they're even around anymore...
-Tad
-
Re: Cheerleaders in Lab Coats
-
-
-
-
Re: Cheerleaders in Lab Coats
-
Tad,
You write "Especially when the investment mix seems to leave a lot of room for improv...
-
Re: Cheerleaders in Lab Coats
-
-
-
-
Re: Cheerleaders in Lab Coats
-
[Sorry for the messy formatting, that was second post via copy-paste.]
-
Re: Cheerleaders in Lab Coats
-
-
-
-
Re: Cheerleaders in Lab Coats
-
Bob Veres' title, "Cheerleaders in Lab Coats," does raise a good question...when I see Ibbotson (...
-
Re: Cheerleaders in Lab Coats
-
-
-
-
Re: Cheerleaders in Lab Coats
-
"Vig has repeatedly demonstrated a palpable animus against commissionable products and those who ...
-
Re: Cheerleaders in Lab Coats
-
-
-
-
Re: Cheerleaders in Lab Coats
-
Vig Goren writes "The problem is with those unscrupulous salesmen pushing unsuitable annuity p...
".
Actually, the problem is with self-appointed critics who make foolish and unsubstantiated summary judgments such as the one above.
Vig has repeatedly demonstrated a palpable animus against commissionable products and those who sell them; he's also demonstrated, repeatedly, that he knows little or nothing about the things he condemns.
The "low-cost" VAs that Vig touts -
(a) do not compensate the seller, which means that either the buyer gets no advice or he must pay extra for it. That doesn't make these contracts bad. It just means that they cannot be compared, head-to-head, with contracts that do compensate the seller for his or her financial advice.
(b) offer limited, IF ANY, "guaranteed living benefits". If one doesn't NEED those features, it's certainly arguable that one shouldn't pay for them, which might suggest a low-fee VA that doesn't offer them. To my mind, a better course might be to avoid buying any VA, if the purchase money is non-qualified. I believe that the benefit of tax-deferral offered by a variable annuity is not worth the cost (All Ordinary Income treatment). But when GLBs are added, the paradigm changes.
Commissionable VAs that include GLBs can offer RISK MANAGEMENT benefits that are arguably unobtainable elsewhere for most buyers. Whether those RM benefits are worth the price charged is certainly arguable, and Peng Chen addressed that issue in his paper. (So did Bob Veres in his response, but Bob made some bad assumptions and presumptions. That said, I have a LOT of respect for Bob Veres; I simply believe he let his bias overwhelm his admirable good sense when he wrote that response). Both Chen and Veres tried to inform us by applying original thought to the issue.
It's an approach I recommend to Vig Goren.
- John Olsen
-
Re: Cheerleaders in Lab Coats
-
-
-
-
Re: Cheerleaders in Lab Coats
-
I usually agree with most of Peng Chenâ??s repor...
I also agree with Bill Reichenstein and Larry Swedroe who wrote the following report on VAs in the NOV 2007 issue of AAII Journal, titled:
Investment Products: If It Has to Be Sold, Don t Buy It!
A few excerpts:But financial firms cannot add value merely by buying securities and combining them into a portfolio. Mutual funds can charge a convenience fee for combining securities into a portfolio and for reinvesting the distributions, but these conveniences can be attained for 0.20% or less. Thus, there is, at best, a very small value added merely from combining securities into a portfolio.
Many investors have not thought about this concept or its investment implications. But it explains why investors should avoid investments and investment products with commissions. This extra charge is only going to a sales person, and that sales person is not providing a serviceâ??or adding valueâ??to the individual investor.
For example, a no-load mutual fund buys securities, puts them together, and sells pro-rata shares of the portfolio s that is, mutual fund share s for cost. The no-load fund does not sell the mutual fund shares for more than the cost; in finance, the value of the whole portfolio does not exceed the sum of the parts.
There are two ways that open-end mutual funds are distributed, that is, two ways that they acquire cash. Some open-end mutual funds are sold by a sales force including brokers, as at AG Edwards and those in a bankâ??s lobby and commission-based financial planners.
Their compensation is based on a one-time upfront sales fee (i.e., front-end load) and sometimes a smaller annual trailing fee, which is part of the 12b-1 fee. Sometimes these fees are as low as 0.35% per year, but they can be considerably higher.
The other distribution method is by direct purchase from the fund or direct marketing. These mutual funds may be purchased via mail, 800 numbers, or directly through supermarkets such as at Charles Schwab.
Because brokers do not receive compensation for selling these direct purchase funds, there is no incentive for them to recommend them.
From an investor s viewpoint, if an investor can select a mutual fund, there is no reason to pay a middlemanâ??s fee. Simply put, the front-end sales commission comes directly from the investor s pocket. The 12b-1 fee is part of the annual expense ratio, so it, too, comes directly from the investorâ??s pocket.
When VAs Make Sense
Investing in a non-qualified variable annuity makes sense only if these three conditions are met:
· 1) The investor has contributed all funds allowed to tax-deferred retirement accounts such as 401(k)s, 403(b)s, and Keoghs and tax-exempt retirement accounts such as Roth IRAs and Roth 401(k)s.
· 2) The investor wants an underlying investment in bonds, REITs, commodities, or some other tax-inefficient investment. As discussed earlier, if an investor wants an underlying investment in stocks, they should invest in a tax-efficient stock fund instead of even a low-cost variable annuity.
· 3) Finally, the annuity should be one of the few low-cost ones such as those offered by TIAA-CREF and Vanguard. Since they avoid salesmen and use low-cost funds, their annual expense ratios are below 1% and they have no surrender fees.
Summary
Unlike manufacturing firms, financial firms cannot add much value by combining parts into a whole. The value of the whole portfolio cannot exceed the value of the sum of the individual securities.
Mutual funds can charge a convenience fee for combining securities into a portfolio and for reinvesting the distributions, but these conveniences can be attained for 0.20% or less. Consequently, investors should not pay much more for a portfolio than the value of the individual securities.
It follows that investors should avoid investments and investment products with commissions, because the extra charge is only going to a sales person providing a service to the financial firm, and not to the individual investor.
These include:· Loaded mutual funds,
· Variable annuities, and
· Equity-indexed annuities. (Although not mentioned in this article, it also includes structured investment products, which often share many characteristics of equity-indexed annuities.)
Due to the compensation system facing brokers, their best interests are opposed to the best interests of their clients. In the best of circumstances, this makes for a tenuous relationship. Our simple warning: If it has to be sold, don t buy it.
*************************************************
As to Bob Veres s article, I assume that Bob has referred only to VA+ GMWB. If it was also aimed at the benefits from f Immediate Variable Annuities (IVAs) , then I am convinced that Bob missed certain FP cases who could benefit from these products greatly. Touching on Bob s argument on VAs vs mutual funds, I happened to have this report of IVAs vs. mutual funds by Rick Carey and Jeff Dellinger showing the upside of IVAs:
PRETAX MONTHLY INCOME FUNDED BY A $500,000
INITIAL INVESTMENT FOR A FEMALE, AGE 65Mutual Fund vs [IVA-Life Annuity]
Probability of......................Initial
Outliving Income................Income
1%.[0%]....................$2,050......[$3,275]
5.....[0]..........................2,157.........[ditto]
10...[0]..........................2,237.........[ditto]
25..[0]...........................2,417.........[ditto]
50..[0]...........................2,739.........[ditto]
71..[0]...........................3,275.........[ditto]
Assumptions:
ð Annuity 2000 Basic Mortality Table
ð 8% investment performance
ð 4% AIR
ð Monthly annuity-due IVA benefits are projected, then mutual fund distributions are set equal to a percentage of IVA benefits so that the mutual fund balance is exhausted when 99%, 95%, 90%, 75%, 50%, and 29% of females originally age 65 have died.
********************************************
-
Re: Cheerleaders in Lab Coats
-
-
-
-
Re: Financial Planners and Healthcare Advice
-
I mean, Vig, are you serious?
Can you name three things the federal government has success...
-
Re: Financial Planners and Healthcare Advice
-
-
-
-
Re: What can I do to pass the CFP?
-
look up Ken Zahn on the web.....greatest review course....take, study and study..you will pass.&n...
-
Re: What can I do to pass the CFP?
-
-
-
-
Re: Financial Planners and Healthcare Advice
-
Vig Goren writes "John Olsen,
Please read this and realize that the LTC issue, on the nati...
-
Re: Financial Planners and Healthcare Advice
-
-
-
-
Re: Cheerleaders in Lab Coats
-
Bob Veres still seems to be missing some pivotal points in Dr. Chen's article. For example,...
-
Re: Cheerleaders in Lab Coats
-
-
-
-
Re: Folks I need some guidance please
-
I have been an employee Financial Consultant for my entire career working for two of the most adv...
-
Re: Folks I need some guidance please
-
-
-
-
Re: Beneficiary to a Beneficiary IRA
-
I got this from Ed Slotts website: as I couldn't find anything on the irs pub 590 that refer...
-
Re: Beneficiary to a Beneficiary IRA
-
-
-
-
Re: Occupations, Worst Clients ???
-
Discussion: occupations, worst clients ???
Posted by Rocket on 11/22/2007
-
Re: Occupations, Worst Clients ???
-
